Email a Friend
Printer Friendly
Slashdot It!
Submit to Reddit
Add to Facebook

Drug dramatically reduces nausea and vomiting in bone marrow transplant patients

March 01, 2010

Bone marrow transplant patients say two of the most debilitating side effects of the treatment are nausea and vomiting caused by chemotherapy and radiation.

But a Loyola University Health System study has found the drug aprepitant can dramatically reduce both nausea and vomiting when combined with other anti-nausea drugs.

Seventy-three percent of patients receiving aprepitant experienced no vomiting during the study period, compared with 23 percent of patients who received a placebo. (Both groups also received a standard anti-nausea drug.) Forty-nine percent of aprepitant patients experienced no vomiting and little or no nausea, compared with 15 percent of the placebo group.

Dr. Patrick Stiff presenting findings at the 2010 BMT Tandem Meetings in Orlando, Fla. His study received a Best Abstract Award from the Center for International Blood & Marrow Transplant Research, one of two organizations sponsoring the meetings. The other sponsor is the American Society for Blood and Marrow Transplantation.

Aprepitant (brand name Emend®) was approved by the Food and Drug Administration in 2003 to help prevent and control vomiting and nausea from chemotherapy. However, there previously had been only a few small studies on the benefit of aprepitant in bone marrow transplant patients, who receive higher doses of chemotherapy than most other cancer patients. "We did not know how effective aprepitant would be for bone marrow transplant patients," Stiff said. "We now believe this should become a standard part of patients' care."

Bone marrow transplant patients say nausea/vomiting is the second-worst side effect of the treatment. (The only thing worse is mouth and throat sores.) Patients can throw up three to five times a day for a week or longer.

Other anti-nausea/vomiting drugs work by blocking signals from the stomach. But signals from the brain still can make a patient queasy. Aprepitant acts to block nausea/vomiting signals from the brain, and is taken together with drugs that block signals from the stomach.

In Stiff's Phase III, blinded, prospective study, 90 bone marrow transplant patients were randomly assigned to receive aprepitant and 89 patients were randomly assigned to receive a placebo.

The aprepitant group did not experience significantly more side effects than the placebo group. Aprepitant also had no meaningful impact on the success of the transplant, relapse rates or overall survival.

Bone marrow transplants are used to treat such diseases as leukemia, lymphoma and Hodgkin's disease. Patients receive high-dose chemotherapy to kill cancer cells. Chemotherapy also kills immune system cells. So patients receive infusions of donated bone marrow cells that develop into healthy new immune cells.

Loyola has the largest bone marrow transplant program in Illinois. "One of the main themes of our research is to make bone marrow transplants more patient-friendly," Stiff said. "Transplants are much more comfortable and easier to tolerate than they were a few years ago."

Previous studies at Loyola were instrumental in showing the effectiveness of the drug palifermin in preventing mouth and throat sores in transplant patients.

Loyola University Health System

Related Bone Marrow Transplant Current Events and Bone Marrow Transplant News Articles

Bone Marrow Transplant Current Events and Bone Marrow Transplant News RSS

Protein that predicts prognosis of leukemia patients may also be a therapeutic target
Researchers at Whitehead Institute and Children's Hospital Boston have identified a protein, called Musashi 2, that is predictive of prognosis in acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) patients.

Compulsive behavior in mice cured by bone marrow transplant
Scientists earlier found that mice missing one of a group of core developmental genes known as the Hox genes developed an odd and rather unexpected pathology: the mutant animals groomed themselves compulsively to the point that they were removing their own hair and leaving self-inflicted open sores on their skin.

Fewer platelets could be used for some cancer and bone-marrow transplantation patients
Physicians may be able to safely lower the platelet dosage in transfusions for cancer and bone-marrow transplant patients without risking increased bleeding, according to new research involving UT Southwestern Medical Center and 28 other medical institutions.

Breakthrough reveals blood vessel cells are key to growing unlimited amounts of adult stem cells
In a leap toward making stem cell therapy widely available, researchers at the Ansary Stem Cell Institute at Weill Cornell Medical College have discovered that endothelial cells, the most basic building blocks of the vascular system, produce growth factors that can grow copious amounts of adult stem cells and their progeny over the course of weeks.

Bone marrow cell transplants to benefit those with heart disease
Two studies published in the latest issue of Cell Transplantation (18:12) may lead to new treatments for the treatment of heart diseases.

Drug that modifies gene activity could help some older leukemia patients
Older patients with acute myeloid leukemia (AML) might benefit from a drug that reactivates genes that cancer cells turn off, according to research at Washington University School of Medicine in St. Louis and collaborating institutions.

Blood test could improve graft-vs.-host disease treatment
University of Michigan researchers have identified the first biomarker of graft-versus-host disease of the skin.

Researchers discover genetic differences between lethal and treatable forms of leukemia
A tumor's genetic profile is often useful when diagnosing and deciding on treatment for certain cancers, but inexplicably, genetically similar leukemias in different patients do not always respond well to the same therapy.

Gene mismatch influences success of bone marrow transplants
A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Genetics.

Scientists successfully reprogram blood cells
Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme -preventing or reducing organ and central nervous system damage from the often-fatal genetic disorder Hurler's syndrome.

More Bone Marrow Transplant Current Events and Bone Marrow Transplant News Articles

	Manual of Stem Cell and Bone Marrow Transplantation (Cambridge Medicine) by Joseph H. Antin MD (Author), Deborah Yolin Raley (Author) Over the past 35 years, stem cell and bone marrow transplantation have evolved from experimental therapies to well-established and widely used treatments for a variety of malignant and nonmalignant conditions. This is a practical pocket manual for all members of the stem cell and bone marrow transplant team, based on a popular in-house handbook used at the Dana-Farber Cancer Institute. The manual covers all aspects of the transplantation process, from stem cell processing through management of transplant-related complications. Evaluation and counseling of patients and donors, preventative care, and conditioning regimens are also covered, making this an ideal resource for nurses as well. The text is handily arranged in outline format to maximize the usefulness and convenience of this...
	Food Safety for Transplant Recipients: A need-to-know guide for bone marrow and solid organ transplant recipients by LittleWhiteEbook.com Food safety is important for everyone — but it’s especially important for you. That’s why the U.S. Department of Agriculture’s Food Safety and Inspection Service has prepared this booklet. It’s designed to provide practical guidance on how to reduce your risk of foodborne illness. In addition to this practical guidance, we encourage you to check with your physician or health care provider to identify foods and other products that you should avoid. You have a special need for this important information . . . so read on!
	With Benefits Also With: Ken Druckerman (Producer), Banks Tarver (Producer)
	The New Normal Life After Bone Marrow Stem Cell Transplant a compelling story of six transplant survivors
	11th Hour Miracles!: Surviving a Bone Marrow Transplant by Analisa Marquez O'Rullian (Author) The need for an inspiring account of the bone marrow transplant process is great! Analisa’s incredible story will leave many to consider the value of spiritual strength as a means for facing life’s unpredictable challenges. “While myriad books treat survival from a medical standpoint, 11th Hour Miracles! does so from a unique viewpoint involving religious faith,” says New York Times best-selling author Ellen Tanner Marsh, “…an approach that sets her account far apart from similar ones.” “It is a moving experience that will help others understand what we transplant doctors see every day, namely the extraordinary strength of the human spirit.” -- Stephen D. Nimer, M.D. Analisa’s amazing story includes the miraculous blood match of her missionary brother living...
	Bone Marrow and Blood Stem Cell Transplants: A Guide For Patients by Susan Stewart (Author) Bone Marrow and Stem Cell Transplants: A Guide for Patients is the next generation of Susan K. Stewart's groundbreaking 1992 book Bone Marrow Transplants: A Book of Basics for Patients. This new 228 paage guide combines solid medical information with the voices of people who have been through a transplant. Comprehensive and easy-to-read, Bone Marrow and Blood Stem Cell Transplants: A Guide for Patients is a goldmine of information for people considering a transplant with donor marrow or stem cells. The book covers a variety of topics and issues such as; History of Transplantation Nuts and Bolts of a Transplant Choosing a Transplant Center Finding a Stem Cell Donor Being a Donor Emotional/Psychological Considerations When Your Child Needs a...
	Bone Marrow and Stem Cell Transplantation by Humana Press This volume is a compendium of cutting-edge molecular methods for the successful transplantation of hematopoietic stem cells. The availability of genetic profiles for committed and uncommitted stem cells combined with the determination of molecular steps involved in hematopoietic stem cell activation and self-renewal hold tremendous promise for future success in the clinic. Currently, stem cells can be quantified and sorted successfully, but transduction, labeling, and in vivo tracking of stem cells are difficult techniques with traditionally low efficiency levels. The contributors to this volume describe promising tools for stem cell transplant research models, such as in vivo bioluminescence imaging. Topics included in this volume are molecular profiling of hematopoietic...
	ABC News Nightline Henry's Story For every medical breakthrough, there are many more patients who undergo experimental treatment only to see it fail. But even though the treatment fails, the patient still plays an important role, and offers a generous gift to our overall understanding of science. Laurie Strongin and Allen Goldberg did not seek the role they played in medical research. They found themselves there unexpectedly in 1995 when their first born, Henry, was diagnosed with a rare and deadly disease called Fanconi Anemia. Immediately, they were thrust onto the frontlines of medical research. Before Henry was a toddler they found themselves in the middle of a debate that would soon grip the nation over embryonic tissue research. But for Laurie and Allen there was never a debate. Doctors told them that the best...
	I Need a Transplant Also With: MTV (Producer)
	A Reason for Optimism: Treating Cancer With a Bone Marrow Transplant by Barbara J. Munson (Author), Connie Marshall (Illustrator)